Society for Functional Precision Medicine (SFPM)

The mission of the Society is to improve patient care and outcomes by facilitating implementation of functional assays into clinical care. The purposes are to foster research and development of functional precision medicine solutions across medicine; to accelerate the dissemination of new and relevant research findings among interested parties; to promote education and training about functional precision medicine; to foster solutions for clinical testing of functional precision medicine approaches; and to improve efficiency of adoption of functional precision medicine solutions through interaction with academia, regulatory bodies, industry, and patients.

https://www.sfpm.io/about.php

https://www.clinicallabmanager.com/insight/tumor-organoids-for-functional-precision-oncology-23300

Human Cancer Models Initiative

https://ocg.cancer.gov/programs/hcmi/overview

Profile of Anthony Letai lab at Dana Farber

https://www.captodayonline.com/predicting-response-to-therapy-with-bh3-profiling/

https://letailab.dana-farber.org/

Nat Med 2017:  Funcational precision cancer medicine - moving beyond pure genomics.  Letai.

https://pubmed.ncbi.nlm.nih.gov/28886003/

NPJ Precis Oncol 2020:  Multiplexed drug testing of tumor slices... Horowitz et al.

https://pubmed.ncbi.nlm.nih.gov/32435696/\

Similarly Rodriguez Lab Chip 2020, https://pubmed.ncbi.nlm.nih.gov/32270149/

___

cscr  zcscr

___

August 2020:  Cancer Genetics (inc) buys "organoid startup Stemonix."  Stemonix develops and manufactures high-density, at-scale human induced pluripotent stem cell-derived neural and cardiac screening platforms for drug discovery and development.  Here.